#######################
# Document Properties #
#######################
SET DOCUMENT Copyright   = "Copyright Â© 2019 Fraunhofer Institute SCAI, All rights reserved."
SET DOCUMENT Licenses    = "CC BY 4.0"
SET DOCUMENT ContactInfo = "charles.hoyt@scai.fraunhofer.de"

SET DOCUMENT Name        = "Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases."
SET DOCUMENT Version     = "1.0.0"
SET DOCUMENT Authors     = "Yojana Gadiya"
SET DOCUMENT Description = ""

##############
# Namespaces #
##############

# Namespaces hosted on https://github.com/pharmacome/conso
# --------------------------------------------------------
# DEFINE NAMESPACE CHEBI          AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/chebi-names.belns"
# DEFINE NAMESPACE CONSO          AS URL "https://raw.githubusercontent.com/pharmacome/conso/4aa36980578c7d2cff07371abf768f15db89cd11/export/conso-names.belns"
# DEFINE NAMESPACE DRUGBANK       AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/drugbank-names.belns"
 DEFINE NAMESPACE DOID           AS URL "https://raw.githubusercontent.com/pharmacome/conso/c0c576e3d3ab9b25a3982251a4ee2fd7c49e1679/external/doid-names.belns"
# DEFINE NAMESPACE ECCODE         AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/ec-code.belns"
# DEFINE NAMESPACE EFO            AS URL "https://raw.githubusercontent.com/pharmacome/conso/5d2c2ea6f7112421cc8089a3f021a75ab60bb373/external/efo-names.belns"
# DEFINE NAMESPACE FB             AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/fb-names.belns"
DEFINE NAMESPACE HGNC           AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc-names.belns"
# DEFINE NAMESPACE HGNCGENEFAMILY AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc.genefamily-names.belns"
# DEFINE NAMESPACE HP             AS URL "https://raw.githubusercontent.com/pharmacome/conso/d9d270e11aac480542c412d4222983a5f042b8ae/external/hp-names.belns"
 DEFINE NAMESPACE GO             AS URL "https://raw.githubusercontent.com/pharmacome/conso/d9d270e11aac480542c412d4222983a5f042b8ae/external/go-names.belns"
# DEFINE NAMESPACE INTERPRO       AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/interpro-names.belns"
 DEFINE NAMESPACE MESH           AS URL "https://raw.githubusercontent.com/pharmacome/conso/f02c6ad4a4791a8ed45448513b9de8c8f1b00c87/external/mesh-names.belns"
# DEFINE NAMESPACE MGI            AS URL "https://raw.githubusercontent.com/pharmacome/conso/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/mgi-names.belns"
 DEFINE NAMESPACE MIRBASE        AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/mirbase-names.belns"
# DEFINE NAMESPACE NCBIGENE       AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/ncbigene.belns"
# DEFINE NAMESPACE PFAM           AS URL "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/pfam-names.belns"
# DEFINE NAMESPACE RGD            AS URL "https://raw.githubusercontent.com/pharmacome/conso/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/rgd-names.belns"

# Namespaces hosted on https://github.com/sorgerlab/famplex
# ---------------------------------------------------------
# DEFINE NAMESPACE FPLX           AS URL "https://raw.githubusercontent.com/sorgerlab/famplex/d9ec0526c20795146a9a6aef17496efe1a36cac6/export/famplex.belns"

# Namespaces defined with regular expressions
# -------------------------------------------
# DEFINE NAMESPACE DBSNP          AS PATTERN "rs[0-9]+"
# DEFINE NAMESPACE TAXONOMY       AS PATTERN "^\d+$"
# DEFINE NAMESPACE UNIPROT        AS PATTERN "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\.\d+)?$"
 DEFINE NAMESPACE PUBCHEM        AS PATTERN "^\d+$"
 DEFINE NAMESPACE NCIT           AS PATTERN "	^C\d+$"

###############
# Annotations #
###############

# Annotations defined with regular expressions
# --------------------------------------------
DEFINE ANNOTATION Species       AS PATTERN "^\d+$"

# Annotations hosted on https://arty.scai.fraunhofer.de/artifactory/bel/annotation
# --------------------------------------------------------------------------------
# DEFINE ANNOTATION Anatomy       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno"
# DEFINE ANNOTATION CellLine      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno"
# DEFINE ANNOTATION CellStructure AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno"
 DEFINE ANNOTATION Cell          AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno"
# DEFINE ANNOTATION Confidence    AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno"
# DEFINE ANNOTATION Disease       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno"
# DEFINE ANNOTATION Gender        AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno"
# DEFINE ANNOTATION MeSHAnatomy   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno"
 DEFINE ANNOTATION MeSHDisease   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
# DEFINE ANNOTATION Subgraph      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno"
# DEFINE ANNOTATION TextLocation  AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"

##############
# Statements #
##############
SET Citation = {"PubMed", "30962309"}

SET Evidence = "Inflammasomes are endogenous multimeric protein complexes that mediate the cleavage of proinflammatory cytokines, especially IL-1beta and IL-18, in response to a diverse set of stimuli such as infections, tissue damage, and metabolic imbalances (1, 2)."
path(MESH:Infection) -> a(MESH:Inflammasomes)
#tissue damage
path(NCIT:C50773) -> a(MESH:Inflammasomes)
path(MESH:Metabolome) -> a(MESH:Inflammasomes)
a(MESH:Inflammasomes) -> deg(p(HGNC:IL1B))
a(MESH:Inflammasomes) -> deg(p(HGNC:IL18))

SET Evidence = "Mutations in genes encoding the inflammasome sensor molecules NLRP3 and pyrin cause
autoinflammatory disorders involving an excessive activation of innate immune responses, namely cryopyrin-associated periodic syndrome and familial Mediterranean fever (3)."
g(HGNC:NLRP3) -> a(MESH:Inflammasomes)
g(HGNC:MEFV) -> a(MESH:Inflammasomes)
#cryopyrin-associated periodic syndrome
p(HGNC:NLRP3, var("?")) -> path(NCIT:C84657)
p(HGNC:MEFV, var("?")) -> path(NCIT:C84657)
p(HGNC:NLRP3, var("?")) -> path(DOID:"familial Mediterranean fever")
p(HGNC:MEFV, var("?")) -> path(DOID:"familial Mediterranean fever")
path(NCIT:C84657) => bp(GO:"activation of innate immune response")
path(DOID:"familial Mediterranean fever") => bp(GO:"activation of innate immune response")
#Autoinflammatory Syndrome/disorder
path(NCIT:C84657) isA path(NCIT:C119050)
path(DOID:"familial Mediterranean fever") isA path(NCIT:C119050)

SET Evidence = "Moreover, changes in inflammasome activity and closely related dysregulation of IL-1beta and IL-18 expression levels have been linked to cancer (4) and various human disorders involving autoimmune processes, such as multiple sclerosis (MS) (5) and rheumatic diseases (6)."
act(a(MESH:Inflammasomes)) -- path(DOID:cancer)
g(HGNC:IL1B) -- path(DOID:cancer)
p(HGNC:IL18) -- path(DOID:cancer)
act(a(MESH:Inflammasomes)) -- path(DOID:"multiple sclerosis")
g(HGNC:IL1B) -- path(DOID:"multiple sclerosis")
p(HGNC:IL18) -- path(DOID:"multiple sclerosis")
act(a(MESH:Inflammasomes)) -- path(DOID:"rheumatic disease")
g(HGNC:IL1B) -- path(DOID:"rheumatic disease")
p(HGNC:IL18) -- path(DOID:"rheumatic disease")
path(DOID:"rheumatic disease") -- path(MESH:Autoimmunity)
path(DOID:"multiple sclerosis") -- path(MESH:Autoimmunity)

SET Evidence = "Several miRNAs can target mRNA transcripts of genes coding for components of inflammasome complexes
or for regulators of the inflammasomes."
r(MESH:MicroRNAs) reg a(MESH:Inflammasomes)

SET Evidence = "The common function of the canonical inflammasomes is the proteolytic activation of IL-1beta and IL-18 and their secretion (2)"
#canonical inflammasomes - NLRP1, NLRP3, NLRC4, AIM2, and pyrin subunits
p(HGNC:NLRP1) -> act(p(HGNC:IL1B))
p(HGNC:NLRP1) -> sec(p(HGNC:IL1B))
p(HGNC:NLRP3) -> act(p(HGNC:IL1B))
p(HGNC:NLRP3) -> sec(p(HGNC:IL1B))
p(HGNC:NLRC4) -> act(p(HGNC:IL1B))
p(HGNC:NLRC4) -> sec(p(HGNC:IL1B))
p(HGNC:AIM2) -> act(p(HGNC:IL1B))
p(HGNC:AIM2) -> sec(p(HGNC:IL1B))
p(HGNC:MEFV) -> act(p(HGNC:IL1B))
p(HGNC:MEFV) -> sec(p(HGNC:IL1B))

p(HGNC:NLRP1) -> act(p(HGNC:IL18))
p(HGNC:NLRP1) -> sec(p(HGNC:IL18))
p(HGNC:NLRP3) -> act(p(HGNC:IL18))
p(HGNC:NLRP3) -> sec(p(HGNC:IL18))
p(HGNC:NLRC4) -> act(p(HGNC:IL18))
p(HGNC:NLRC4) -> sec(p(HGNC:IL18))
p(HGNC:AIM2) -> act(p(HGNC:IL18))
p(HGNC:AIM2) -> sec(p(HGNC:IL18))
p(HGNC:MEFV) -> act(p(HGNC:IL18))
p(HGNC:MEFV) -> sec(p(HGNC:IL18))

SET Evidence = "Noncanonical inflammasomes have been proposed to realize additional functions such as the mediation of programmed cell death (pyroptosis) and the initiation of NLRP3 assembly (8, 9)."
#noncanonical inflammasomes - caspase-4, caspase-5, and caspase-8
p(HGNC:CASP4) -> path(MESH:Pyroptosis)
p(HGNC:CASP4) -> bp(GO:"NLRP3 inflammasome complex assembly")
p(HGNC:CASP5) -> path(MESH:Pyroptosis)
p(HGNC:CASP5) -> bp(GO:"NLRP3 inflammasome complex assembly")
p(HGNC:CASP8) -> path(MESH:Pyroptosis)
p(HGNC:CASP8) -> bp(GO:"NLRP3 inflammasome complex assembly")

SET Evidence = "Moreover, the inflammasomes control the microbiome in humans, both by hindering invasion of pathogens and by regulating the composition of commensal bacteria (10)."
a(MESH:Inflammasomes) reg path(MESH:Microbiota)
a(MESH:Inflammasomes) =| path(MESH:"Host-Pathogen Interactions")

SET Evidence = "In mouse models, deficiency of inflammasome components enhances the susceptibility to inflammatory bowel diseases (IBD) (10)."
SET Species = "10090"
a(MESH:Inflammasomes) =| path(DOID:"inflammatory bowel disease")
UNSET Species

SET Evidence = "Furthermore, several therapies that are currently in use to treat autoimmune disorders, such as IFN-beta and glatiramer acetate in MS, glucocorticoids in systemic lupus erythematosus (SLE), and the TNF-alpha inhibitor infliximab in rheumatic diseases, partially affect the regulation of inflammasomes (11â14)."
a(PUBCHEM:223370366) -| path(DOID:"multiple sclerosis")
a(PUBCHEM:3081884) -| path(DOID:"multiple sclerosis")
a(PUBCHEM:223370366) reg a(MESH:Inflammasomes)
a(PUBCHEM:3081884) reg a(MESH:Inflammasomes)

a(PUBCHEM:53787563) -| path(DOID:"systemic lupus erythematosus")
a(PUBCHEM:53787563) reg a(MESH:Inflammasomes)

a(PUBCHEM:135305802) -| path(DOID:"rheumatic disease")
a(PUBCHEM:135305802) =| p(HGNC:TNF)
a(PUBCHEM:135305802) reg a(MESH:Inflammasomes)

SET Evidence = "It is composed of the sensor molecule NLRP3, the adapter protein ASC that enhances complex formation, and of proâcaspase-1."
#It - NLRP3 inflammasome
#PYCARD - ASC
complex(GO:"NLRP3 inflammasome complex") hasComponents list(p(HGNC:NLRP3), p(HGNC:PYCARD), p(HGNC:CASP1))

SET Evidence = "Upon assembly, the activated inflammasome converts proâcaspase-1 into caspase-1, which cleaves proâIL-1b and proâIL-18 into mature proinflammatory cytokines IL-1b and IL-18 (15). The proinflammatory cytokines are then secreted (16)."
act(complex(GO:"NLRP3 inflammasome complex")) -> sec(p(HGNC:IL1B))
act(complex(GO:"NLRP3 inflammasome complex")) -> sec(p(HGNC:IL18))

SET Evidence = "In the brain, and in particular the microglia, NLRP3 mRNA levels are among the highest throughout human tissues (18, 19)."
a(MESH:Brain) -> r(HGNC:NLRP3, loc(MESH:Microglia))

SET Evidence = "For example, the miRNAs miR-20b-5p, miR-30a-5p, and miR-146a-5p are dysregulated in immunological and neurologic pathways in MS (22), and the miRNA levels in peripheral blood cells of MS patients change in response to IFN-beta treatment (23)."
SET MeSHDisease = "Multiple Sclerosis"
a(MIRBASE:"hsa-mir-20a") -- path(MESH:"Neural Pathways")
a(MIRBASE:"hsa-mir-20a") -- path(MESH:"Immune System")
a(MIRBASE:"hsa-mir-30a") -- path(MESH:"Neural Pathways")
a(MIRBASE:"hsa-mir-30a") -- path(MESH:"Immune System")
a(MIRBASE:"hsa-mir-146a") -- path(MESH:"Neural Pathways")
a(MIRBASE:"hsa-mir-146a") -- path(MESH:"Immune System")
SET Cell = "blood cell"
a(PUBCHEM:223370366) reg a(MIRBASE:"hsa-mir-20a")
a(PUBCHEM:223370366) reg a(MIRBASE:"hsa-mir-30a")
a(PUBCHEM:223370366) reg a(MIRBASE:"hsa-mir-146a")
UNSET Cell
UNSET MeSHDisease

SET Evidence = "The first step of canonical miRNA biogenesis is transcription into primary miRNAs (pri-miRNAs) by RNA polymerase II (24, 25)."
act(p(MESH:"RNA Polymerase II"), ma(GO:"rRNA transcription")) -> r(NCIT:C25967)

SET Evidence = "In a two-step process, the primiRNA is first cleaved into a precursor miRNA by Drosha/
DGCR8 and additional RNA-binding proteins, translocated into the cytoplasm by exportin-5, and subsequently processed
by Dicer/TRBP to form a short miRNA duplex (26â28)."
p(HGNC:DGCR8) -> r(NCIT:C25967, frag("?"))
p(HGNC:DROSHA) -> r(NCIT:C25967, frag("?"))
r(NCIT:C25967, frag("?")) -> r(MESH:MicroRNAs)
p(HGNC:XPO5) -> a(MESH:"RNA-Binding Proteins", loc(GO:cytoplasm))
composite(a(MESH:"RNA-Binding Proteins"), p(HGNC:DICER1)) -> complex(p(MESH:MicroRNAs), p(MESH:MicroRNAs))
composite(a(MESH:"RNA-Binding Proteins"), p(HGNC:NCOA6)) -> complex(p(MESH:MicroRNAs), p(MESH:MicroRNAs))

SET Evidence = ""
